C3 and systemic lupus erythematosus: Markers of SLE activity, including serum complement 3 (C3), C4, and anti-double stranded DNA antibody (anti-dsDNA Ab), are conventional biomarkers for assessing disease severity (15) but lack sufficient sensitivity and specificity for histological classification of LN (16).